[ad_1]
(Photo = AP = Yonhap News)
Modena, an American biotech company that developed a new vaccine against coronavirus infection (Corona 19), announced that its vaccine is more effective than Pfizer-Bioentech’s Corona 19 vaccine, which has already begun to be vaccinated in the United States.
It is argued that the Modena vaccine not only prevents the onset of COVID-19 symptoms, but also prevents the infection itself.
On the 15th (local time), the CNN broadcast reported that Modena disclosed this in a document additionally sent to the United States Food and Drug Administration (FDA).
CNN noted that these advantages will give Modena’s vaccine an advantage over Pfizer’s rival vaccine. This is because Pfizer’s vaccine only demonstrated that even if infected with Corona 19, it prevents the infection from progressing to the level where symptoms appear, including serious illnesses.
So far, the Modena vaccine has been found to be 94.5% effective in preventing serious illness from 14 days after the second vaccination.
Moderna claims that the vaccine has been shown to prevent both asymptomatic and symptomatic infections.
To determine whether the vaccine reduced the infection rate during the clinical trial, the Modena researchers took samples from the test participants’ noses before each vaccination and performed tests for COVID-19. The Modena vaccine should be given twice, 4 weeks apart.
As a result, 14 of the people who were negative in the first test were positive for Corona 19 in the second test, in the group that received the vaccine, and 38 in the group that received the placebo. No one showed symptoms.
“Compared to the placebo group, about two-thirds fewer people tested positive on the second test,” he said. “This suggests that some asymptomatic infections began to be prevented after the first dose.” Explained.
Moderna said the initial request for emergency use authorization (USA) had not yet been able to include such data because it was not available.
The Vaccines and Biologicals Advisory Committee (VRBPAC), an advisory body to the FDA, will hold a meeting on the 17th and decide whether to recommend the urgent use of modders or vaccines.
Eunji Cha, Reporter Hankyung.com [email protected]
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution
